Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.
Saved in:
| Title: | Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3. |
|---|---|
| Authors: | Liu C; Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Jalagam PR; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Feng J; Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Wang W; Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Raja T; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Sura MR; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Manepalli RKVLP; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Aliphedi BR; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Medavarapu S; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Nair SK; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Muthalagu V; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Natesan R; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Gupta A; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Beno B; Department of Computer-Aided Drug Design & Molecular Analytics, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Panda M; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Ghosh K; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Shukla JK; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Sale H; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Haldar P; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Kalidindi N; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Shah D; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India., Patel D; Department of Metabolism and Pharmacokinetics, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Mathur A; Department of Discovery Synthesis, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Ellsworth BA; Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Cheng D; Department of Cardiovascular and Fibrosis Discovery Biology, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States., Regueiro-Ren A; Department of Small Molecule Drug Discovery, Research & Early Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2022 Aug 25; Vol. 65 (16), pp. 11084-11099. Date of Electronic Publication: 2022 Aug 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
